Recent Finacing
Recent Raise
ImmuneBridge is a cell therapy manufacturing platform that uses machine-learning donor screening and a proprietary small molecule to preserve stem-cell pluripotency and scale production.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at ImmuneBridge.
